Related Experiment Videos
Diabetes self-management profile short form: a preliminary report
Richard F Ittenbach1, Amy E Cassedy, Jennifer M Rohan
1Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, MLC 5041, 3333 Burnet Avenue, Cincinnati, OH 45229, USA. richard.ittenbach@cchmc.org
Journal of Clinical Psychology in Medical Settings
|July 25, 2012
Summary
A new short form of the Diabetes Self-Management Profile (DSMP-SF) effectively screens children with type 1 diabetes. This tool aids in identifying high-risk patients for better glycemic control.
Area of Science:
- Pediatric Endocrinology
- Psychometrics
- Diabetes Management
Background:
- Effective family management is crucial for glycemic control in children with type 1 diabetes.
- The Diabetes Self-Management Profile (DSMP) is a tool used to assess self-management patterns.
- A shorter, validated version could improve screening efficiency.
Purpose of the Study:
- To develop and provide preliminary evidence for a reduced form of the DSMP using Rasch modeling.
- To assess the validity of the reduced form by correlating it with key diabetes indicators.
Main Methods:
- Secondary analysis of DSMP data from 239 preadolescent children with type 1 diabetes.
- Rasch modeling techniques were employed to select the most informative items.
- A seven-item short form (DSMP-SF) was created, encompassing all original subscales.
Main Results:
- The DSMP-SF was successfully developed, comprising seven items across all five original subscales.
- The DSMP-SF composite score showed a significant correlation with hemoglobin A1c (HbA1c).
- The DSMP-SF composite score also correlated significantly with blood glucose monitoring (BGM) frequency.
Conclusions:
- The DSMP-SF is a valid and effective screening tool for pediatric type 1 diabetes self-management.
- It serves as a practical alternative to the original DSMP, especially for identifying at-risk children.
- This shortened version can enhance the efficiency of diabetes management assessments in clinical settings.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:14SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...